Literature DB >> 24762560

A randomized, controlled trial to increase discussion of breast cancer in primary care.

Celia P Kaplan1, Jennifer Livaudais-Toman2, Jeffrey A Tice3, Karla Kerlikowske3, Steven E Gregorich4, Eliseo J Pérez-Stable5, Rena J Pasick3, Alice Chen3, Jessica Quinn2, Leah S Karliner5.   

Abstract

BACKGROUND: Assessment and discussion of individual risk for breast cancer within the primary care setting are crucial to discussion of risk reduction and timely referral.
METHODS: We conducted a randomized controlled trial of a multiethnic, multilingual sample of women ages 40 to 74 years from two primary care practices (one academic, one safety net) to test a breast cancer risk assessment and education intervention. Patients were randomly assigned to control or intervention group. All patients completed a baseline telephone survey and risk assessment (via telephone for controls, via tablet computer in clinic waiting room before visit for intervention). Intervention (BreastCARE) patients and their physicians received an individualized risk report to discuss during the visit. One-week follow-up telephone surveys with all patients assessed patient-physician discussion of family cancer history, personal breast cancer risk, high-risk clinics, and genetic counseling/testing.
RESULTS: A total of 655 control and 580 intervention women completed the risk assessment and follow-up interview; 25% were high-risk by family history, Gail, or Breast Cancer Surveillance Consortium risk models. BreastCARE increased discussions of family cancer history [OR, 1.54; 95% confidence interval (CI), 1.25-1.91], personal breast cancer risk (OR, 4.15; 95% CI, 3.02-5.70), high-risk clinics (OR, 3.84; 95% CI, 2.13-6.95), and genetic counseling/testing (OR, 2.22; 95% CI, 1.34-3.68). Among high-risk women, all intervention effects were stronger.
CONCLUSIONS: An intervention combining an easy-to-use, quick risk assessment tool with patient-centered risk reports at the point of care can successfully promote discussion of breast cancer risk reduction between patients and primary care physicians, particularly for high-risk women. IMPACT: Next steps include scaling and dissemination of BreastCARE with integration into electronic medical record systems. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24762560      PMCID: PMC4167008          DOI: 10.1158/1055-9965.EPI-13-1380

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  31 in total

1.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

2.  Alcohol consumption and breast cancer risk in the Women's Health Study.

Authors:  Shumin M Zhang; I-Min Lee; JoAnn E Manson; Nancy R Cook; Walter C Willett; Julie E Buring
Journal:  Am J Epidemiol       Date:  2007-01-04       Impact factor: 4.897

3.  Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.

Authors:  Celia Patricia Kaplan; Jennifer S Haas; Eliseo J Pérez-Stable; Steven E Gregorich; Carol Somkin; Genevieve Des Jarlais; Karla Kerlikowske
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

Review 4.  Physical activity and good nutrition: essential elements to prevent chronic diseases and obesity 2003.

Authors: 
Journal:  Nutr Clin Care       Date:  2003 Oct-Dec

Review 5.  American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.

Authors:  Rowan T Chlebowski; Nananda Col; Eric P Winer; Deborah E Collyar; Steven R Cummings; Victor G Vogel; Harold J Burstein; Andrea Eisen; Isaac Lipkus; David G Pfister
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

6.  Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care.

Authors:  Heather J Baer; Louise I Schneider; Graham A Colditz; Hank Dart; Analisa Andry; Deborah H Williams; E John Orav; Jennifer S Haas; George Getty; Elizabeth Whittemore; David W Bates
Journal:  J Gen Intern Med       Date:  2013-01-31       Impact factor: 5.128

7.  Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization.

Authors:  Douglas E Levy; Judy E Garber; Alexandra E Shields
Journal:  J Gen Intern Med       Date:  2009-05-20       Impact factor: 5.128

8.  Genetics in primary care: a USA faculty development initiative.

Authors:  Wylie Burke; Louise Acheson; Jeffery Botkin; Kenneth Bridges; Ardis Davis; James Evans; Jaime Frias; James Hanson; Norman Kahn; Ruth Kahn; David Lanier; Linda E Pinsky; Nancy Press; Michele A Lloyd-Puryear; Eugene Rich; Nancy Stevens; Elizabeth Thomson; Steven Wartman; Modena Wilson
Journal:  Community Genet       Date:  2002

9.  The gap between practice and genetics education of health professionals: HuGEM survey results.

Authors:  E V Lapham; C Kozma; J O Weiss; J L Benkendorf; M A Wilson
Journal:  Genet Med       Date:  2000 Jul-Aug       Impact factor: 8.822

10.  Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population.

Authors:  Cecelia A Bellcross; Amy A Lemke; Laura S Pape; Angela L Tess; Lorraine T Meisner
Journal:  Genet Med       Date:  2009-11       Impact factor: 8.822

View more
  16 in total

1.  A Cluster Randomized Trial of a Personalized Multi-Condition Risk Assessment in Primary Care.

Authors:  Jennifer S Haas; Heather J Baer; Katyuska Eibensteiner; Elissa V Klinger; Stella St Hubert; George Getty; Phyllis Brawarsky; E John Orav; Tracy Onega; Anna N A Tosteson; David W Bates; Graham Colditz
Journal:  Am J Prev Med       Date:  2016-09-14       Impact factor: 5.043

2.  Views of Low-Income Women of Color at Increased Risk for Breast Cancer.

Authors:  Emily E Anderson; Silvia Tejada; Richard B Warnecke; Kent Hoskins
Journal:  Narrat Inq Bioeth       Date:  2018

3.  Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.

Authors:  Katherine D Crew
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

4.  Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.

Authors:  Jennifer Livaudais-Toman; Leah S Karliner; Jeffrey A Tice; Karla Kerlikowske; Steven Gregorich; Eliseo J Pérez-Stable; Rena J Pasick; Alice Chen; Jessica Quinn; Celia P Kaplan
Journal:  Breast       Date:  2015-10-21       Impact factor: 4.380

5.  Randomized Trial of Personalized Breast Density and Breast Cancer Risk Notification.

Authors:  Jennifer S Haas; Catherine S Giess; Kimberly A Harris; Julia Ansolabehere; Celia P Kaplan
Journal:  J Gen Intern Med       Date:  2018-08-08       Impact factor: 5.128

6.  Behavioral Economics: A New Lens for Understanding Genomic Decision Making.

Authors:  Scott Emory Moore; Holley H Ulbrich; Kenneth Hepburn; Bonnie Holaday; Rachel Mayo; Julia Sharp; Rosanne H Pruitt
Journal:  J Nurs Scholarsh       Date:  2018-04-24       Impact factor: 3.176

7.  Acceptability of an Interactive Computer-Animated Agent to Promote Patient-Provider Communication About Breast Density: a Mixed Method Pilot Study.

Authors:  Christine Gunn; Ariel Maschke; Timothy Bickmore; Mark Kennedy; Margaret F Hopkins; Michael D C Fishman; Michael K Paasche-Orlow; Erica T Warner
Journal:  J Gen Intern Med       Date:  2020-01-09       Impact factor: 5.128

8.  A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.

Authors:  Kent F Hoskins; Silvia Tejeda; Ganga Vijayasiri; Ifeanyi Beverly Chukwudozie; Mylene H Remo; Hiral A Shah; Ivy E Abraham; Lara E Balay; Tara K Maga; Ericka R Searles; Veena J Korah; Alana Biggers; Melinda R Stolley; Richard B Warnecke
Journal:  Cancer       Date:  2018-10-15       Impact factor: 6.860

9.  Validation of an Efficient Screening Tool to Identify Low-Income Women at High Risk for Hereditary Breast Cancer.

Authors:  Susan L Stewart; Celia P Kaplan; Robin Lee; Galen Joseph; Leah Karliner; Jennifer Livaudais-Toman; Rena J Pasick
Journal:  Public Health Genomics       Date:  2016-10-28       Impact factor: 2.000

Review 10.  Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?

Authors:  Thomas C Randall; Katrina Armstrong
Journal:  Curr Treat Options Oncol       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.